
Loading, please wait...

Loading, please wait...

Cannabis and alcohol impairment significantly affects road safety, especially as the consumption of edibles grows in popularity. Simultaneous use of these substances represents a major public health concern for clinicians and emergency responders. Furthermore, controlled data on how oral THC interacts with alcohol have historically been scarce. A recent double-blind crossover trial at the Johns Hopkins University School of Medicine has addressed this gap. The researchers found that combining these substances produces impairment that far exceeds the effects of using either one alone.
Specifically, the study evaluated healthy adults who consumed cannabis-infused brownies and alcohol in a controlled environment. Consequently, the researchers could measure the individual and interactive effects on simulated driving. They utilized the Global Drive Score (GDS) to quantify performance decrements. Notably, the combination of 25 mg of THC with a breath alcohol concentration (BrAC) of 0.05% caused significantly more impairment than alcohol alone at the 0.08% limit. However, the study observed that low-dose THC (10 mg) had a negligible impact when used without alcohol.
In addition, the trial highlighted a major limitation in current roadside detection methods. Moreover, participants often failed simulated driving tasks while still passing Standardized Field Sobriety Tests (SFSTs). This discrepancy suggests that traditional behavioral tests may not effectively identify cannabis and alcohol impairment. Therefore, clinicians must educate patients about the synergistic risks of co-use, as subjective confidence often does not match objective performance. For instance, many participants felt capable of driving despite showing marked deficits in reaction time and lane control.
Thus, these findings suggest that the 0.08% BrAC limit might be too liberal for drivers who also consume cannabis. Because the pharmacokinetic profile of THC remained unchanged by alcohol, the increased impairment likely stems from a pharmacodynamic interaction. Similarly, the public health need for improved impairment detection strategies is now more pressing than ever. Finally, as legalization expands, medical professionals should remain vigilant in counseling patients about the prolonged and unpredictable effects of cannabis edibles.
No, the study results indicated that THC and metabolite pharmacokinetics remained unaffected by alcohol consumption. The increased impairment is likely due to how the substances interact within the central nervous system rather than a change in absorption.
The research suggests they are not fully reliable. Many participants showed significant driving decrements even when they did not exhibit enough clues to fail a standardized field sobriety test.
The study found that driving impairment at the legal limit (0.08% BrAC) was significantly worsened by the addition of cannabis. This suggests that the current legal threshold may not be safe for those who co-use these substances.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Zamarripa CA et al. Impact of Cannabis Edibles Combined With Alcohol on Driving, Field Sobriety Performance, and Subjective Effects: A Within-Participant Crossover Trial. JAMA Netw Open. 2026 May 01. doi: 10.1001/jamanetworkopen.2026.9842. PMID: 42065887.
Marcotte TD et al. Can Field Sobriety Tests Identify Drivers Under the Influence of Cannabis? JAMA Psychiatry. 2023;80(10):979–986. doi:10.1001/jamapsychiatry.2023.2345.
National Institute on Drug Abuse (NIDA). Research Reports: Marijuana. National Institutes of Health. Updated 2025.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A crossover trial shows that cannabis edibles and alcohol combined significantly worsen driving impairment compared to using either substance alone....
5 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today